ProfileGDS4132 / 231886_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 31% 38% 46% 36% 39% 35% 36% 42% 41% 31% 36% 33% 45% 43% 30% 35% 36% 54% 37% 35% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10176.23931
GSM201543Muscle PCOS pioglitazone 12190.412938
GSM201544Muscle PCOS pioglitazone 161123.29346
GSM201545Muscle PCOS pioglitazone 20199.325236
GSM201829Muscle PCOS pioglitazone 231106.81839
GSM201830Muscle PCOS pioglitazon 25190.422535
GSM201831Muscle PCOS pioglitazone 27190.923236
GSM201832Muscle PCOS pioglitazone 31108.32342
GSM201833Muscle PCOS pioglitazone 4198.334141
GSM201834Muscle PCOS pioglitazone 8174.31831
GSM201835Muscle PCOS after pioglitazone 10276.783436
GSM201836Muscle PCOS after pioglitazone 12273.145733
GSM201837Muscle PCOS after pioglitazone 162102.59345
GSM201838Muscle PCOS after pioglitazone 202101.39543
GSM201839Muscle PCOS after pioglitazone 23267.055730
GSM201840Muscle PCOS after pioglitazone 25284.105635
GSM201841Muscle PCOS after pioglitazone 27276.400636
GSM201842Muscle PCOS after pioglitazone 32122.94154
GSM201843Muscle PCOS after pioglitazone 4292.577337
GSM201844Muscle PCOS after pioglitazone 8282.574835